A population-based, multifaceted strategy to implement antenatal corticosteroid treatment versus standard care for the reduction of neonatal mortality due to preterm birth in low-income and middle-income countries: the ACT cluster-randomised trial

F. Althabe,J. M. Belizán,E. M. McClure,J. Hemingway-Foday,M. Berrueta,A. Mazzoni,A. Ciganda,S. S. Goudar,B. S. Kodkany,N. S. Mahantshetti,S. M. Dhaded,G. M. Katageri,M. C. Metgud,A. M. Joshi,M. B. Bellad,N. V. Honnungar,R. J. Derman,S. Saleem,O. Pasha,S. Ali,F. Hasnain,R. L. Goldenberg,F. Esamai,P. Nyongesa,S. Ayunga,E. A. Liechty,A. L. Garces,L. Figueroa,K. M. Hambidge,N. F. Krebs,A. Patel,A. Bhandarkar,M. Waikar,P. L. Hibberd,E. Chomba,W. A. Carlo,A. Mwiche,M. Chiwila,A. Manasyan,S. Pineda,S. Meleth,V. Thorsten,K. Stolka,D. D. Wallace,M. Koso-Thomas,A. H. Jobe and P. M. Buekens. A population-based, multifaceted strategy to implement antenatal corticosteroid treatment versus standard care for the reduction of neonatal mortality due to preterm birth in low-income and middle-income countries: the ACT cluster-randomised trial. Lancet. 2015;385(9968):10.1016/s0140-6736(14)61651-2.